The latest data from the phase 1 trial are encouraging,” said the study's lead author.
A new type of mRNA vaccine, added to standard cancer treatment, could help some patients with pancreatic cancer live longer.
A new study from Memorial Sloan Kettering Cancer Center shows good results for patients with pancreatic cancer. They used a ...
A new study from Karolinska Institutet has found that people with chronic kidney disease (CKD) are significantly more likely ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results